Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,891 public trials 2,118 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor

NCT04100733

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Hospital of West Jutland Holstebro, Danmark, Denmark

Aarhus University Hospital Århus N, Denmark

Zealand University Hospital Roskilde, Denmark

View Trial Details

Active, not recruiting

Hong Kong Breast Cancer Study

NCT02889458

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +13 more
Locations: Baptist Hospital Hong Kong

Caritas Medical Centre Hong Kong

Evangel Hospital Hong Kong

Grantham Hospital Hong Kong

View all 21 locations

View Trial Details

Active, not recruiting

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

NCT03306121

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

NCT03488667

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Active, not recruiting

Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II)

NCT04928222

Conditions: Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
Locations: Beer Dermatology West Palm Beach, Florida, United States

New York and Presbyterian Hospital New York, United States

View Trial Details

Active, not recruiting

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

NCT05459415

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
Locations: Zhanjie Zhang Wuhan, Hubei, China

View Trial Details

Active, not recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations: The University of Arizona Cancer Center Tucson, Arizona, United States

Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States

Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States

Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States

View all 23 locations

View Trial Details

Active, not recruiting

Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer

NCT03308396

Conditions: Adenocarcinoma, Advanced Kidney Cancer, Carcinoma, +16 more
Locations: Univerisity of Illinois Cancer Center Chicago, Illinois, United States

University of Iowa Hosptials and Clinics Iowa City, Iowa, United States

University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Active, not recruiting

Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma

NCT03179943

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations: USC Norris Hospital and Clinics Los Angeles, California, United States

Johns Hopkins University School of Medicine Baltimore, Maryland, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)

NCT01688908

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Laboratory of genetics, Peking University cancer Hospital and institute Beijing, Beijing Municipality, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions